Mary Freyvogel, DO
Mary E. Freyvogel, DO, is a breast surgeon at University Hospitals Seidman Cancer Center and a Clinical Assistant Professor of Surgery at the Case Western Reserve University School of Medicine. She joined University Hospitals in August of 2014.
Dr. Freyvogel is board certified in General Surgery and completed a Breast Surgery fellowship at the Cleveland Clinic.
Her research interests are in breast cancer, benign breast disease, high-risk evaluation and surveillance and breast cancer survivorship.
She is a member of the American Society of Breast Surgeons, the Society of Surgical Oncology, the American College of Osteopathic Surgeons and the Association of Women Surgeons.
Dr. Freyvogel graduated with a bachelor’s degree in biological sciences from North Carolina State University. She received her D.O. degree from the Lake Erie College of Osteopathic Medicine in Erie, Pa. She served her general surgery residency at McLaren Macomb Hospital in Mt. Clemens, MI. and completed a breast surgery fellowship at the Cleveland Clinic.
- Breast Cancer
- Breast Cancer Surveillance
- Breast Disease
- High Risk Assessment and Surveillance
Patient Satisfaction Reviews
4.9 out of 5
Patient Comments (2)
Reviewed On 7/13/2018
Dr. Freyvogel and her staff are amazing! They are kind, caring, articulate, and patient. I've recommended her to several friends. UH doctors diagnosed me with a life saving immune issue and my breast cancer.
Reviewed On 6/13/2018
The Dr & all the Ladies that work in the Breast Center were so nice.
- Surgery - American Osteopathic Board of Surgery
Fellowship | Breast Surgery
Breast Surgery - Cleveland Clinic (2013 - 2014)
Residency | General Surgery
General Surgery - Mclaren Macomb Regional Medical Center (2008 - 2013)
Lake Erie College Of Osteopathic Medicine (2008)
North Carolina State University (2004)
Breast cancer, High-risk evaluation and surveillance, Breast cancer survivorship
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Mary Freyvogel did not disclose any Outside Relationships with Industry.